Company Filing History:
Years Active: 2011
Title: Degenhardt Thorsten: Innovator in Diabetic Treatment
Introduction
Degenhardt Thorsten is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetic complications. His innovative work has led to the development of a unique patent that addresses critical health issues faced by diabetic patients.
Latest Patents
Degenhardt holds a patent for "Pyridoxamine for the treatment of diabetic intermediaries and post-amadori inhibition." This invention provides pharmaceutical compositions that include dosage units of pyridoxamine, or a pharmaceutically acceptable salt thereof, along with a pharmaceutically acceptable carrier. The methods outlined in this patent aim to limit the progression of renal disease and diabetic complications in human diabetic patients. He has 1 patent to his name.
Career Highlights
Degenhardt is associated with Nephrogenex, Inc., a company focused on developing innovative therapies for kidney diseases. His work at Nephrogenex has been instrumental in advancing treatment options for patients suffering from diabetes-related complications.
Collaborations
Degenhardt collaborates with notable colleagues, including Schotzinger Robert and Fox J Wesley. Their combined expertise contributes to the ongoing research and development efforts at Nephrogenex.
Conclusion
Degenhardt Thorsten's contributions to diabetic treatment through his patent and work at Nephrogenex highlight his commitment to improving patient outcomes. His innovative approach continues to pave the way for advancements in the pharmaceutical industry.